Sanofi SA (SAN.FR) said Monday that its unit Sanofi Aventis France is
being investigated by Paris prosecutors over its Depakine drug used to
treat epilepsy.
The French pharmaceutical giant said the investigation is related to
pregnant women suffering from epilepsy and using Depakine, which, when
the treatment is suddenly interrupted, could cause birth malfunctions
and risk the mother’s life.
The investigation will allow the company to defend itself and prove that it has fulfilled its duty of transparency, Sanofi said.
https://www.marketscreener.com/SANOFI-4698/news/Sanofi-France-Investigates-Sanofi-Over-Epilepsy-Drug-29937206/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.